Sopharma AD (BUL:SFA) commences share repurchases on December 1, 2023, under the program mandated by the shareholders in the Extraordinary General Meeting held on August 4, 2023. As per the mandate, the company is authorized to repurchase up to 3% of its own shares, each calendar year. The shares will be repurchased at a minimum price of not lower than the nominal value of one share of the company's capital and maximum price BGN 6.50 per share.

The plan will be valid for 18 months. As of August 4, 2023, the company had 134,797,899 shares in issue of which 13,479,188 shares were in treasury.